Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1999
11/30/1999US5993841 Treating or disorder of the nervous system comprising topically applying an antibiotic; an antihistamine; and a carrier; wherein said antibiotic and said antihistamine are present in relative amounts of 30:70 to 70:30% by weight
11/30/1999US5993826 Relates generally to various outer membrane proteins (omps) of moraxella catarrhalis for use as targets in immunotherapy
11/30/1999US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
11/30/1999US5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
11/30/1999US5993823 Cytotoxic T lymphocyte-inducing lipopeptides and methods of use
11/30/1999US5993821 Antigens and vaccines containing said vlps that may be effective in treatment of infections caused by such viruses.
11/30/1999US5993819 Amino acid sequences corresponding to antigenic determinants of the envelope glycoprotein of hiv, covalently coupled, directly or through a spacer molecule, to carrier molecules suitable for vaccination of mammals.
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993812 Method of delaying the progression of an infection with the human immunodeficiency virus
11/30/1999US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/30/1999US5993809 The method and composition eliminates problems associated with conventional antibiotic treatments, such as inefficacy and promotion of antibiotic resistant bacterial strains.
11/30/1999US5993808 Chitinase, DNA coding therefor and plants containing same
11/30/1999US5993787 Composition base for topical therapeutic and cosmetic preparations
11/30/1999US5993785 Mouthwash compositions
11/30/1999CA1340832C Recombinant cmv neutralizing proteins
11/30/1999CA1340831C Ribozymes
11/25/1999WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999WO1999059997A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
11/25/1999WO1999059994A1 Retroviral protease inhibiting compounds
11/25/1999WO1999059989A1 Process for the preparation of a benzo fused heterocyclo sulfonyl halide intermediate
11/25/1999WO1999059984A1 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity
11/25/1999WO1999059981A1 Thermally stable trimetrexates and processes for producing the same
11/25/1999WO1999059961A1 Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions
11/25/1999WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999WO1999059630A1 Type iii bordetella secretion system
11/25/1999WO1999059629A1 Humanized antibodies that recognize verotoxin ii and cell line producing same
11/25/1999WO1999059626A1 Compositions and method for immunizing poultry
11/25/1999WO1999059625A1 Vaccine delivery system
11/25/1999WO1999059621A1 Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having g chronic hepatitis c infection
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059616A1 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
11/25/1999WO1999059615A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059601A1 Use of a nucleic acid-binding chemotherapeutic agent, and a pharmaceutical composition
11/25/1999WO1999059587A1 Anti-viral compounds
11/25/1999WO1999059585A1 Compositions for the treatment of hiv and other viral infections
11/25/1999WO1999059568A1 Hydroxamic acid derivatives as antibacterials
11/25/1999WO1999059553A1 Effervescent preparations
11/25/1999WO1999059525A2 Broad spectrum microbicidal and spermicidal compositions, devices, and methods
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1999045957A3 Combined vaccine compositions
11/25/1999WO1999043344A3 Matrix protein compositions for wound healing
11/25/1999WO1999035271A3 Vibrio cholerae vaccine candidates and method of their constructing
11/25/1999DE19823097A1 Pharmaceutical comprising an alpha-protein
11/25/1999DE19820801A1 Oral dosage form for gatifloxacin, providing reproducible decomposition time and drug release
11/25/1999CA2333274A1 Thermally stable trimetrexates and processes for producing the same
11/25/1999CA2332403A1 Anti-viral compounds
11/25/1999CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999CA2332246A1 Compositions and method for immunizing poultry
11/25/1999CA2331823A1 Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having g chronic hepatitis c infection
11/25/1999CA2331756A1 Retroviral protease inhibiting compounds
11/25/1999CA2329877A1 Compositions for the treatment of hiv and other viral infections
11/25/1999CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation
11/25/1999CA2327100A1 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
11/24/1999EP0958373A1 Vaccines
11/24/1999EP0958364A1 Immunotherapy and improved vaccines
11/24/1999EP0958307A1 O-sulfated bacterial polysaccharides
11/24/1999EP0958289A1 Amino acid ester containing azole antifungals
11/24/1999EP0958283A1 New compounds with hemoregulating effect
11/24/1999EP0957936A1 Formulations of recombinant papillomavirus vaccines
11/24/1999EP0957927A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
11/24/1999EP0957913A1 N-linked sulfonamides of heterocyclic thioesters
11/24/1999EP0957907A1 Il-8 receptor antagonists
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0957900A1 Compositions and methods for topical application of therapeutic agents
11/24/1999EP0822831B1 Vaccines containing a saponin and a sterol
11/24/1999EP0805790B1 Improved synthesis of cyclopropylacetylene
11/24/1999EP0739205B1 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections
11/24/1999EP0730470A4 Improved interferon polymer conjugates
11/24/1999CN1236393A Chitinase materials and methods
11/24/1999CN1236369A New Knoevenagel condensation products, method for their production and use
11/24/1999CN1236366A Amino acid ester containing azole antifungals
11/24/1999CN1236320A Therapeutic uses of BPI protein products for human meningococcemia
11/24/1999CN1236319A Pharmaceutical composition containing a mixed extract of phellodondron amurense amurense ruprecht cortex and patrinia scabiosaefolia fish for treatment of hepatitis C
11/24/1999CN1046729C Novel carbapenem derivative
11/24/1999CN1046727C HIV protease inhibitors
11/24/1999CN1046720C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
11/24/1999CN1046715C Process for making HIV protease inhibitors
11/24/1999CN1046691C Method for colouring piece of rock by laser rays
11/23/1999US5990388 Transgenic plant expressing a cloned dna encoding a vaccinia virus e3l protein at a level to complex and sequester double-stranded rna-like structure of virus/viroid; biological pest control; viricides
11/23/1999US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders
11/23/1999US5990156 Viricides for the influenza virus; neuraminidase inhibitors; also parainfluenza, mumps, newcastle disease virus and sendai virus; myxovirus
11/23/1999US5990155 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
11/23/1999US5990148 Side effect reductions; antiarthritic agents; nonsteroidal antiinflammatory agents
11/23/1999US5990136 Isoxazoline derivatives useful as antimicrobials
11/23/1999US5990122 Substituted in the 7-position by a tricyclic amine radical; reduced genotoxic properties and increased antibacterial activity
11/23/1999US5990093 Treating hepatitis b virus (hbv) infections by administering a 5'-phospholipid prodrug of beta-l-2',3'-dideoxyadenosine 5'-monophosphate of given structure optionally with other anti-hbv agents, such as carbovir or 3tc
11/23/1999US5990090 A double-stranded dna nf-kappab inhibitor of given nucleotide sequence is effective for the treatment of immune and inflammatory diseases, cancer, and viral infections
11/23/1999US5990086 Therapeutic uses of BPI protein products for human meningococcemia
11/23/1999US5989905 HCV NS3 protein fragments having helicase activity and improved solubility
11/23/1999US5989895 β-(1-3)-glucanosyltransferase, oligonucleotides encoding this enzyme, and molecules having effects on this enzyme
11/23/1999US5989884 Polypeptides of the histidyl transfer rna synthetase family; for screening of antibiotics, bactericides, and bacteristats for treatment and prevention of clamydial infections; diagnosis
11/23/1999US5989864 DNA encoding spo-rel polypeptides
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989841 Testing foods; contacting with antibodies; detecting immunological complex
11/23/1999US5989832 Method for screening for non-tetracycline efflux pump inhibitors
1 ... 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 ... 1798